Department of Anesthesiology and Intensive Care Unit, Cantonal Hospital Zenica, 67 Crkvice St, 72 000, Zenica, Bosnia and Herzegovina.
University Department of Anesthesiology, Resuscitation and Intensive Care, Clinical Hospital Sveti Duh, 64 Sveti Duh St, 10 000, Zagreb, Croatia.
Int J Colorectal Dis. 2019 Sep;34(9):1551-1561. doi: 10.1007/s00384-019-03349-4. Epub 2019 Jul 15.
This study aimed to evaluate the effect of preoperative carbohydrate oral (CHO) loading on the postoperative metabolic and inflammatory response, perioperative discomfort and surgical clinical outcomes in open colorectal surgery compared with a conventional fasting protocol.
Fifty patients were randomly allocated to either the intervention group (CHO), to receive preoperative oral carbohydrate supplementation, or the control group (FAST), to undergo preoperative fasting. Insulin resistance, insulin sensitivity, the Glasgow Prognostic Score (GPS) and IL-6 levels were analysed at 06 h on the day of surgery (T), 6 h after surgery (T) and at 06 h on postoperative day 1 (T) and postoperative day 2 (T). Thirst, hunger, dry mouth, weakness, anxiety and pain were assessed using the visual analogue scale (VAS) prior to anaesthesia induction and at 0-4, 4-8, 8-12 and 12-24 h after surgery. Surgical clinical outcomes included the return of gastrointestinal function, time to independent ambulation and postoperative discharge day.
Postoperative insulin resistance was 30% lower (p < 0.03) and insulin sensitivity was 15% higher (p < 0.05) in the CHO group than in the FAST group. The GPS was lower in the CHO group at T (p < 0.001), T (p < 0.01) and T (p < 0.004). IL-6 serum levels were lower at the analysed postoperative time points in the CHO group (p < 0.001). The VAS well-being score was lower in the intervention group (p < 0.001); however, the VAS pain score was not significantly different between the groups. The evaluated surgical outcomes appeared earlier in the CHO group (p < 0.001).
A preoperative CHO drink reduced the postoperative metabolic and inflammatory response and improved subjective well-being and surgical clinical outcomes but did not diminish the VAS pain score.
本研究旨在评估与传统禁食方案相比,术前口服碳水化合物(CHO)负荷对开腹结直肠手术患者术后代谢和炎症反应、围手术期不适和手术临床结局的影响。
将 50 例患者随机分为干预组(CHO),术前口服碳水化合物补充,或对照组(FAST),术前禁食。分别于手术当天 06:00(T)、术后 6:00(T)和术后第 1 天 06:00(T)及术后第 2 天 06:00(T)分析胰岛素抵抗、胰岛素敏感性、格拉斯哥预后评分(GPS)和白细胞介素-6(IL-6)水平。在麻醉诱导前和术后 0-4、4-8、8-12 和 12-24 h 时,使用视觉模拟评分(VAS)评估口渴、饥饿、口干、乏力、焦虑和疼痛。手术临床结局包括胃肠功能恢复、独立行走时间和术后出院日。
与 FAST 组相比,CHO 组术后胰岛素抵抗降低 30%(p<0.03),胰岛素敏感性升高 15%(p<0.05)。CHO 组在 T(p<0.001)、T(p<0.01)和 T(p<0.004)时 GPS 较低。CHO 组在分析的术后时间点 IL-6 血清水平较低(p<0.001)。干预组 VAS 舒适度评分较低(p<0.001);然而,两组间 VAS 疼痛评分无显著差异。CHO 组的评估手术结局更早出现(p<0.001)。
术前 CHO 饮料可减少术后代谢和炎症反应,改善主观舒适度和手术临床结局,但不降低 VAS 疼痛评分。